BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29498920)

  • 21. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
    Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
    PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and Epigenetic Causes of Pituitary Adenomas.
    Chang M; Yang C; Bao X; Wang R
    Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotroph adenoma with secondary hypersecretion of testosterone.
    Chamoun R; Layfield L; Couldwell WT
    World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial pituitary tumors.
    Alband N; Korbonits M
    Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas.
    Foltran RK; Amorim PVGH; Duarte FH; Grande IPP; Freire ACTB; Frassetto FP; Dettoni JB; Alves VA; Castro I; Trarbach EB; Bronstein MD; Jallad RS
    Braz J Med Biol Res; 2018 Jun; 51(9):e7427. PubMed ID: 29947650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetic testing in the management of pituitary disease.
    Coopmans EC; Korbonits M
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double separate versus contiguous pituitary adenomas: MRI features and endocrinological follow up.
    Roberts S; Borges MT; Lillehei KO; Kleinschmidt-DeMasters BK
    Pituitary; 2016 Oct; 19(5):472-81. PubMed ID: 27209585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1.
    Sanno N; Itoh J; Teramoto A; Itoh Y; Hori S; Osamura RY
    J Neurooncol; 1997 Oct; 35(1):29-38. PubMed ID: 9266438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Aspects of Pituitary Adenomas.
    Marques P; Korbonits M
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):335-374. PubMed ID: 28476226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
    Daly AF; Tichomirowa MA; Petrossians P; Heliövaara E; Jaffrain-Rea ML; Barlier A; Naves LA; Ebeling T; Karhu A; Raappana A; Cazabat L; De Menis E; Montañana CF; Raverot G; Weil RJ; Sane T; Maiter D; Neggers S; Yaneva M; Tabarin A; Verrua E; Eloranta E; Murat A; Vierimaa O; Salmela PI; Emy P; Toledo RA; Sabaté MI; Villa C; Popelier M; Salvatori R; Jennings J; Longás AF; Labarta Aizpún JI; Georgitsi M; Paschke R; Ronchi C; Valimaki M; Saloranta C; De Herder W; Cozzi R; Guitelman M; Magri F; Lagonigro MS; Halaby G; Corman V; Hagelstein MT; Vanbellinghen JF; Barra GB; Gimenez-Roqueplo AP; Cameron FJ; Borson-Chazot F; Holdaway I; Toledo SP; Stalla GK; Spada A; Zacharieva S; Bertherat J; Brue T; Bours V; Chanson P; Aaltonen LA; Beckers A
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E373-83. PubMed ID: 20685857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
    Karhu A; Aaltonen LA
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.
    Münscher A; Schmid M; Saeger W; Schreiber S; Lüdecke DK
    Endocr Pathol; 2001; 12(2):171-80. PubMed ID: 11579683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features.
    Ferretti E; Jaffrain Rea ML; Asteria C; Di Stefano D; Esposito V; Ferrante L; Daniele P; Tiberti C; Gallucci M; Bosman C; Alesse E; Gulino A; Beck-Peccoz P; Tamburrano G
    Eur J Endocrinol; 2001 Mar; 144(3):227-35. PubMed ID: 11248741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
    Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
    J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic mutations in sporadic pituitary adenomas--what to screen for?
    Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
    Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Gonadotropin and Adrenocorticotropic Hormone Secretion on Invasiveness of Clinically Nonfunctioning Pituitary Adenomas: A Cell Culture Study.
    Usui S; Hama S; Tominaga A; Kinoshita Y; Kurisu K
    World Neurosurg; 2016 Dec; 96():578-584.e1. PubMed ID: 27601155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.